Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase

Abstract

Immunomodulatory drugs bind to cereblon (CRBN) to confer differentiated substrate specificity on the CRL4(CRBN) E3 ubiquitin ligase. Here we report the identification of a new cereblon modulator, CC-885, with potent anti-tumour activity. The anti-tumour activity of CC-885 is mediated through the cereblon-dependent ubiquitination and degradation of the translation termination factor GSPT1. Patient-derived acute myeloid leukaemia tumour cells exhibit high sensitivity to CC-885, indicating the clinical potential of this mechanism. Crystallographic studies of the CRBN-DDB1-CC-885-GSPT1 complex reveal that GSPT1 binds to cereblon through a surface turn containing a glycine residue at a key position, interacting with both CC-885 and a 'hotspot' on the cereblon surface. Although GSPT1 possesses no obvious structural, sequence or functional homology to previously known cereblon substrates, mutational analysis and modelling indicate that the cereblon substrate Ikaros uses a similar structural feature to bind cereblon, suggesting a common motif for substrate recruitment. These findings define a structural degron underlying cereblon 'neosubstrate' selectivity, and identify an anti-tumour target rendered druggable by cereblon modulation.

Overview

Integrity signals

Registry

Crossref · 10.1038/nature18611

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

28 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 34 references

Cited by

See all 720

Metadata

Authors
Matyskiela, M. E., Lu, G., Ito, T., Pagarigan, B., Lu, C.-C., Miller, K., Fang, W., Wang, N.-Y., Nguyen, D., Houston, J., Carmel, G., Tran, T., Riley, M., Nosaka, L., Lander, G. C., Gaidarova, S., Xu, S., Ruchelman, A. L., Handa, H., Carmichael, J., Daniel, T. O., Cathers, B. E., Lopez-Girona, A., & Chamberlain, P. P.
Affiliations
  • Tokyo Medical University (JP)
  • Scripps Research Institute (US)
Corresponding author
  • Lu, Gang
  • Chamberlain, Philip P.
Venue
Nature
Published
2016-06-22
Volume
535
Issue
7611
Pages
252-257
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2470671857
Cited by
701
References
34
Citations by year
2026: 96 · 2025: 124 · 2024: 90 · 2023: 71 · 2022: 72 · 2021: 78 · 2020: 62 · 2019: 42 · 2018: 31 · 2017: 30 · 2016: 4
FWCI
18.70
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • Japan Society for the Promotion of Science (26750374)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
cereblon, GSPT1, E3 ubiquitin ligase, immunomodulators, acute myeloid leukemia, substrate recruitment, Ikaros, translation termination factor, ubiquitination, drug repurposing, crystal structure, lenalidomide
MeSH terms
Antineoplastic Agents, Binding Sites, DNA-Binding Proteins, Humans, Models, Molecular, Peptide Hydrolases, Peptide Termination Factors, Phenylurea Compounds, Protein Binding, Substrate Specificity, Thalidomide, Crystallography, X-Ray, Amino Acid Motifs, Ubiquitin-Protein Ligases, Multiprotein Complexes, Adaptor Proteins, Signal Transducing, Ikaros Transcription Factor, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase. https://app.cochat.ai/papers/10.1038/nature18611
The paper
Matyskiela, M. E., Lu, G., Ito, T., Pagarigan, B., Lu, C.-C., Miller, K., Fang, W., Wang, N.-Y., Nguyen, D., Houston, J., Carmel, G., Tran, T., Riley, M., Nosaka, L., Lander, G. C., Gaidarova, S., Xu, S., Ruchelman, A. L., Handa, H., . . . Chamberlain, P. P. (2016). A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase. Nature. https://doi.org/10.1038/nature18611

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.